Spain (ES)

Design and methodology of the screening for CKD among older patients across Europe (SCOPE) study: a multicenter cohort observational study (2018) Corsonello A, Tap L, Roller-Wirnsberger R, Wirnsberger G, Zoccali C, Kostka T, Guligowska A, et al. Journal article A proposal to create an extension to the European baseline series (2018) Wilkinson M, Gallo R, Goossens A, Johansen JD, Rustemeyer T, Sanchez-Perez J, Schuttelaar ML, Uter W Journal article SUNNIFORECAST - A phase II study of Nivolumab in combination with Ipilimumab versus Standard of care in advanced or metastatic non-clear cell renal cell carcinoma (2018) Scheich S, Ahrens M, Goekbuget N, Boleti E, Burkholder , Escudier BJ, Goebell P, et al. Conference contribution Self-testing for contact allergy to hair dyes - a 5-year follow-up multicentre study (2018) Friis UF, Goosens A, Gimenez-Arnau AM, Liden C, Gimenez-Arnau E, White IR, Alfonso JH, et al. Journal article Induction of VEGF secretion from bone marrow stromal cell line (ST-2) by the dissolution products of mesoporous silica glass particles containing CuO and SrO (2018) Balasubramanian P, Salinas AJ, Sanchez-Salcedo S, Detsch R, Vallet-Regi M, Boccaccini AR Journal article, Original article Bioactive coatings on porous titanium for biomedical applications (2018) Dominguez-Trujillo C, Ternero F, Rodriguez-Ortiz JA, Heise S, Boccaccini AR, Lebrato J, Torres Y Journal article, Original article Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study (2018) Feagan BG, Panes J, Ferrante M, Kaser A, D'Haens GR, Sandborn WJ, Louis E, et al. Journal article Serum IP-10 levels and increased DPPIV activity are linked to circulating CXCR3+ T cells in cholestatic HCV patients (2018) Rau M, Schmitt J, Berg T, Kremer A, Stieger B, Spanaus K, Bengsch B, et al. Journal article Long-term safety of adalimumab in patients with moderate-to-severe ulcerative colitis: Interim results of a non-interventional registry, LEGACY (2018) Bossuyt P, Atreya R, Taxonera C, Hebuterne X, Isaacs K, Higgins PD, Lindsay J, et al. Conference contribution Pre-Treatment Tumor Growth Rate (TGR0) in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs) Treated with Systemic Therapies: Subgroup Analysis of the GREPONET Study (2018) Crona J, Lamarca A, Ronot M, Opalinska M, Lopez Lopez C, Pezzutti D, Vidal Trueba H, et al. Conference contribution